{"cluster": 49, "subcluster": 30, "abstract_summ": "The enduring epidemic outbreak which started in Wuhan city of China, in December 2019 caused by the 2019 novel coronavirus (COVID- 19) or the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has created a dangerous and deadly Public Health disaster of International apprehension, with cases confirmed in several countries.It was initially called the 2019 novel coronavirus (2019-nCoV) and has been recently relabelled as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); the disease it causes has been named coronavirus disease 2019 (COVID-19).Human coronaviruses were first identified in 1965 and are responsible for the respiratory tract infections in major proportion of population worldwide; at least five new human coronaviruses have been identified, including severe acute respiratory syndrome coronavirus (SARS-CoV) in 2002\u20132003 and Middle East respiratory syndrome coronavirus (MERS-CoV) in 2012.The symptoms vary from asymptomatic, low grade pyrexia, dry cough, sore throat, breathlessness, tiredness, body aches, fatigue, myalgia, nausea, vomiting, diarrhea, to severe consolidation and pneumonia, acute respiratory distress syndrome (ARDS) and multiple organ dysfunction leading to death with case fatality rate ranging from 2 to 3%.Through literature review and group discussion, Special Expert Group for Control of the Epidemic of Novel Coronavirus Pneumonia of the Chinese Preventive Medicine Association formulated an update on the epidemiological characteristics of novel coronavirus pneumonia (NCP).The novel coronavirus disease (COVID-19) or also known as the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has been recognized as the cause of respiratory infection in Wuhan, Hubei Province, China, in late December 2019.", "title_summ": "Phylogenetic analyses of the severe acute respiratory syndrome coronavirus 2 reflected the several routes of introduction to Taiwan, the United States, and JapanEmergence of deadly severe acute respiratory syndrome coronavirus-2 during 2019\u20132020A Review of Coronavirus Disease-2019 (COVID-19)Coronavirus Disease: A Review of a New Threat to Public HealthImmune-epidemiological parameters of the novel coronavirus \u2013 a perspectiveSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a reviewEpidemiology of CoViD-19 Pandemic: Recovery and mortality ratio around the globeAn overview of coronaviruses including the SARS-2 coronavirus \u2013 Molecular biology, epidemiology and clinical implicationsCounting the cost of COVID-19Classical CoronavirusesGlobal Trends in Epidemiology of Coronavirus Disease 2019 (COVID-19)Coronavirus: Hotspot on coronavirus disease 2019 in IndiaCoronavirus Disease of 2019: a Mimicker of Dengue Infection?COVID-19: a review.[An update on the epidemiological characteristics of novel coronavirus pneumonia\uff08COVID-19\uff09].Overview of Coronavirus Disease 2019 (COVID-19): Treatment Updates and Advances.Effects of temperature on COVID-19 transmission[Coronavirus and COVID-19 : focus on a galopping pandemic].2019 Novel Coronavirus Outbreak: SOS Alert for Dentists.An alternative approach to minimize the risk of coronavirus (Covid-19) and similar infections.", "title_abstract_phrases": "It was initially called the 2019 novel coronavirus (2019-nCoV) and has been recently relabelled as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); the disease it causes has been named coronavirus disease 2019 (COVID-19).The enduring epidemic outbreak which started in Wuhan city of China, in December 2019 caused by the 2019 novel coronavirus (COVID- 19) or the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has created a dangerous and deadly Public Health disaster of International apprehension, with cases confirmed in several countries.The symptoms vary from asymptomatic, low grade pyrexia, dry cough, sore throat, breathlessness, tiredness, body aches, fatigue, myalgia, nausea, vomiting, diarrhea, to severe consolidation and pneumonia, acute respiratory distress syndrome (ARDS) and multiple organ dysfunction leading to death with case fatality rate ranging from 2 to 3%.[An update on the epidemiological characteristics of novel coronavirus pneumonia\uff08COVID-19\uff09].Through literature review and group discussion, Special Expert Group for Control of the Epidemic of Novel Coronavirus Pneumonia of the Chinese Preventive Medicine Association formulated an update on the epidemiological characteristics of novel coronavirus pneumonia (NCP).Human coronaviruses were first identified in 1965 and are responsible for the respiratory tract infections in major proportion of population worldwide; at least five new human coronaviruses have been identified, including severe acute respiratory syndrome coronavirus (SARS-CoV) in 2002\u20132003 and Middle East respiratory syndrome coronavirus (MERS-CoV) in 2012.Coronavirus: Hotspot on coronavirus disease 2019 in IndiaThe novel coronavirus disease (COVID-19) or also known as the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has been recognized as the cause of respiratory infection in Wuhan, Hubei Province, China, in late December 2019."}